SARS-CoV-2 seropositivity and subsequent infection risk: a prospective cohort study

This publication has 7 references indexed in Scilit:

• Occupational risk of SARS-CoV-2 infection and reinfection during the second pandemic surge: a cohort study
  Occupational and Environmental Medicine, 2021
• Impact of baseline SARS-CoV-2 antibody status on syndromic surveillance and the risk of subsequent COVID-19—a prospective multicenter cohort study
  BMC Medicine, 2021
• Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, Italy
  JAMA Internal Medicine, 2021
• SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study
  The Lancet Respiratory Medicine, 2021
• Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI): a prospective cohort study
  The Lancet Healthy Longevity, 2021
• Risk of Reinfection After Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Population-based Propensity-score Matched Cohort Study
  Clinical Infectious Diseases, 2021
• SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)
  The Lancet, 2021